Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock

Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation.

Summary from the CNBC news feed. Copyright belongs to CNBC.

Opens in a new tab, so Investz stays open.

ShareEmail X LinkedIn Facebook Reddit WhatsApp

More headlines

CNBCAnthropic IPO live updates: AI lab expects to spend at least $542B on data centers in coming years CNBCFTC and 20 states sue Dollar General, alleging retailer overcharged shoppers MarketWatchNvidia, AMD and Broadcom could buy Meta shares as part of $35 billion stock offering CNBCBuying America at a discount: This timberland REIT is on sale CNBCTrump DOJ unlawfully fired Epstein prosecutor Maurene Comey, judge rules MarketWatchMy wife has only $80,000 saved for retirement. I have $2.2 million. Am I wrong to be shocked?

Headlines and summaries come from publishers’ public news feeds and are shown with attribution and a link to the original. Investz does not write or endorse them and they are not investment advice. Disclosures.